Canada ups release rate from J&J's contraceptive patch
This article was originally published in Scrip
Executive Summary
The Canadian label for Janssen-Ortho's (Johnson & Johnson) contraceptive transdermal patch, Evra (norelgestromin 6mg plus ethinylestradiol 0.6mg), has been amended to say that more of its active ingredients are released when used by patients.